{"id":"NCT01243671","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease","officialTitle":"A Multi-Center Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10","primaryCompletion":"2012-03","completion":"2013-06","firstPosted":"2010-11-18","resultsPosted":"2013-05-15","lastUpdate":"2014-07-25"},"enrollment":20,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Intestinal Behçet's Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Adalimumab","otherNames":["ABT-D2E7, Humira"]}],"arms":[{"label":"Adalimumab","type":"EXPERIMENTAL"}],"summary":"To investigate efficacy, safety and pharmacokinetics of adalimumab subcutaneous (sc) for Japanese subjects with intestinal Behçet's disease who are refractory to conventional therapies.","primaryOutcome":{"measure":"Number of Participants With Marked Improvement at Week 24","timeFrame":"24 weeks","effectByArm":[{"arm":"Adalimumab","deltaMin":9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":12,"countries":["Japan"]},"refs":{"pmids":["28670237","25245624"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":20},"commonTop":["NASOPHARYNGITIS","HEADACHE","BACK PAIN","COUGH","DENTAL CARIES"]}}